Filing Details
- Accession Number:
- 0001133416-24-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-16 16:12:20
- Reporting Period:
- 2024-10-16
- Accepted Time:
- 2024-10-16 16:12:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522478 | D Kevin Freeman | C/O Galectin Therapeutics Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-16 | 5,000 | $2.70 | 33,469 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-10-16 | 5,000 | $2.70 | 80,000 | No | 4 | P | Indirect | By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,063 | Indirect | IRA |
Footnotes
- Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
